Trial pipeline
Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.
Free access · No subscription for research tools or data exports
Filter the development pipeline
6 trials match this view; 14 reported facilities; 14 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 250 across 6 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Milestones to investigate
The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.
For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyHospice · Psilocybin · Demoralization · Terminal Illness · Cancer-related Problem/Condition · Psychotherapy · Terminal Cancer · Cancer Terminal | Yvan Beaussant, MD, MSci PHASE2 | Completed Registry updated 2026-02-17 | 15 ACTUAL | 2022-03-09 2024-07-27 2025-12-31 | |
| Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional HealthDemoralization | University of Alabama at Birmingham EARLY_PHASE1 | Withdrawn Registry updated 2026-03-11 | 0 ACTUAL | 2023-08-15 2026-03 2026-03 | |
| Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of LifeDemoralization | Charles S. Grob, M.D. PHASE2 | Recruiting Registry updated 2025-11-25 | 100 ESTIMATED | 2025-01-19 2026-12-31 2027-12-31 | |
| Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyDemoralization · Safety | Gustavo Vazquez PHASE1 | Recruiting Registry updated 2026-03-18 | 15 ESTIMATED | 2026-04-01 2027-06-01 2027-06-01 | |
| Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)Palliative Care · Pain · Anxiety · Depression · Demoralization · Psychological Distress · Quality of Life · Caregiver Burden · Fear of Death · Existential Distress | University Hospital, Basel, Switzerland PHASE2 | Recruiting Registry updated 2026-04-29 | 60 ESTIMATED | 2024-06-09 2027-09 2028-05 | |
| High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialAdvanced Cancer · Demoralization · Existential Distress · Psychological Distress | University of Calgary PHASE2 | Not yet recruiting Registry updated 2026-09-02 | 60 ESTIMATED | 2026-10-30 2027-12-20 2027-12-31 |
Reported research facilities
Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada · Coordinates available
Providence Care HospitalKingston, Ontario, Canada · Coordinates available
Queen's UniversityKingston, Ontario, Canada · Coordinates available
Spital Uster AG, Division of Internal MedicineUster, Switzerland · Coordinates available
University Hospital Basel, Division of Clinical Pharmacology and ToxicologyBasel, Switzerland · Coordinates available
University Hospital Geneva, Palliative medicine departmentCollonge-Bellerive, Switzerland · Coordinates available
University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative CareZurich, Switzerland · Coordinates available
Care DimensionsDanvers, Massachusetts, United States · Coordinates available
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterTorrance, California, United States · Coordinates available
Marin Cancer CareGreenbrae, California, United States · Coordinates available
Sunstone TherapiesRockville, Maryland, United States · Coordinates available
University of Alabama at BirminghamBirmingham, Alabama, United States · Coordinates available
University of California, Los AngelesLos Angeles, California, United States · Coordinates available
University of San FranciscoSan Francisco, California, United States · Coordinates available
This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.